In vitro characterization of cytochrome P450 2D6 inhibition by classic histamine H1 receptor antagonists

Drug Metabolism and Disposition

Volumn 26, Issue 6, 1998, Pages 536-539

  Hamelin, Bettina A ^a   Bouayad, Asmaa ^b   Drolet, Benoît ^b   Gravel, Anne ^b   Turgeon, Jacques ^b  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPHENIRAMINE; CLEMASTINE; CYTOCHROME P450; CYTOCHROME P450 2D6; CYTOCHROME P450 ISOENZYME; DIPHENHYDRAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; PERPHENAZINE; TRIPELENNAMINE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION KINETICS; DRUG METABOLISM; DRUG POTENCY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE COMPLEX; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CYTOCHROME P-450 CYP2D6; HISTAMINE H1 ANTAGONISTS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031768733     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Alvan G (1991) Clinical consequences of polymorphic drug oxidation. Fundam Clin Pharmacol 5:209-228.
2. Athanikar NK, Peng GW, Nation RL, Huang SM and Chiou WL (1979) Chlorpheniramine. 1. Rapid quantitative analysis of chlorpheniramine in plasma, saliva and urine by high-performance liquid chromatography. J Chromatogr 162:367-376.
3. Berlinger WG, Goldberg MJ, Spector R, Chiang CK and Ghoneim MM (1982) Diphenhydramine: kinetics and psychomotor effects in elderly women. Clin Pharmacol Ther 32:387-391.
4. Blyden GT, Greenblatt DJ, Scavone JM and Shader RI (1986) Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration. J Clin Pharmacol 26:529-533.
5. Bouayad A, Desgagnés P, Jobin J, Poirier P, Turgeon J and Hamelin BA (1997) Diphenhydramine alters hemodynamic effects of metopiolol in man. Can J Cardiol 13:81C (abstract).
6. Brosen K, Gram LF, Haghfelt T and Bertilsson L (1987) Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment. Pharmacol Toxicol 60:312-314.
7. Carruthers SG, Shoeman DW, Hignite CE and Azarnoff DL (1978) Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther 23:375-382.
8. Chiou WL, Athanikar NK and Huang SM (1979) Long half-life of chlorpheniramine. N Engl J Med 300:501.
9. de Groot MJ, Bijloo GJ, Martens BJ, van Acker FAA and Vermeulen NPE (1997) A refined substrate model for human cytochrome P450 2D6. Chem Res Toxicol 10:41-48.
10. Fonne-Pfister R and Meyer UA (1988) Xenobiotic and endobiotic inhibitors of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism. Biochem Pharmacol 37:3829-3835.
11. Glassman JN, Dugas JE, Tsuang MT and Loyd DW (1985) Idiosyncratic pharmacokinetics complicating treatment of major depression in an elderly woman. J Ment Nerv Dis 173:573-576.
12. Hiroi T, Ohíshi N, Imaoka S, Yabusaki Y, Fukui H and Funae Y (1995) Mepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms. J Pharmacol Exp Ther 272:939-944.
13. Huang SM, Athanikar NK, Sridhar K, Huang YC and Chiou WL (1982) Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults. Eur J Clin Invest 22:359-365.
14. 14C-labeled quaternary ammonium salt of mepazine and promethazine in rats. J Pharm Sci 59:772-775.
15. Jones GR and Pounder DJ (1987) Site dependence of drug concentrations in postmortem blood: a case study. J Anal Toxicol 11:186-190.
16. 3H by the rat and dog. Biochem Pharmacol 18:659-671.
17. Kronbach T, Mathys D, Gut J, Catin T and Meyer UA (1987) High-performance liquid Chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Anal Biochem 162:24-32.
18. Lennard MS (1993) Genetically determined adverse drug reactions involving metabolism. Drug Safety 9:60-77.
19. Mahgoub A. Idle JR, Dring LG, Lancaster R and Smith RL (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet 2:584-586.
20. 1 antagonist promethazine in human liver microsomes. Pharmacogenetics 6:449-457.
21. 1-receptor antagonists (the antihistamines). Clin Pharmacokinet 10:477-497.
22. 14C in rats. J Pharm Sci 63:1527-1532.
23. Rao GS, Krishna G and Gillette JR (1975) Metabolism, tissue distribution and covalent binding of tripelennamine and its N-nitroso derivative in the rat. J Pharmacol Exp Ther 195:433-440.
24. Rekka E, Timmermann H and Bast A (1989) Structural features of some diphenhydramine analogues that determine the interaction with rat liver cytochrome P-450. Agents Actions 27:184-187
25. 1-receptor-antagonist drugs. N Engl J Med 330:1663-1669.
26. 1 receptor antagonist hydroxyzine. J Allergy Clin Immunol 73:69-75.
27. Spector R, Choudhury AK, Chiang CK, Goldberg MJ and Ghoneim MM (1980) Diphenhydramine in Orientals and Caucasians, Clin Pharmacol Ther 28:229-234.
28. Taylor G and Houston JB (1982) Simultaneous determination of promethazine and two of its circulating metabolites by high-performance liquid chromatography. J Chromatogr 230:194-198.
29. Tham R, Norlander B, Hagermark O and Fransson L (1978) Gas-chromatography of clemastine: A study of plasma kinetics and biological effect. Drug Res 28:1017-1020.
30. Tonn GR, Kwan E, Hall C, Riggs KW, Axelson JE and Rurak DW (1996) Hepatic first-pass uptake of diphenhydramine: A comparative study between fetal and adult sheep. Drug Metab Dispos 24:273-281.
31. 1-receptor occupancy. Clin Pharmacol Ther 58:210-220.
32. Yeh SY, Todd GD, Johnson RE, Gorodetzky CW and Lange WR (1986) The pharmacokinetics of pentazocine and tripelennamine. Clin Pharmacol Ther 39:669-676.